SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Zora Neale Hurston Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientZora Neale Hurston
Date of birth1891-01-07
IdentifiersMRN HR-ML040-SYN-TD; SSN (made up) 000-40-6213
Document date2026-11-01
AuthorLorraine Abernathy-Osei, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing care for morning headaches, breathlessness on exertion and ankle swelling, with very high blood pressure: examination, ECG, laboratory tests, 24-hour ambulatory blood pressure monitoring, a two-drug combination, food and medicine-cost screening, and stroke warning signs. Concerns: She wants to keep teaching, writing and gardening, and to get her breath back; She cannot afford expensive medicines or extra trips, and food runs short at the end of the month; She wants her own account of her symptoms to be believed and every choice explained. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Amlodipine 5 mg oral tablet, one tablet every morningOne tablet every morningOral route1958-03-09activeS
Chlorthalidone 25 mg oral tablet, one-half tablet (12.5 mg) every morningOne-half tablet every morningOral route1958-03-09activeS
Dapagliflozin 10 mg oral tablet, one tablet daily; pause on days of vomiting, diarrhea or not eating or drinkingOne tablet daily, with sick-day rulesOral route1958-03-23activeS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route1958-03-23activeS
Spironolactone 25 mg oral tablet, one-half tablet (12.5 mg) dailyOne-half tablet dailyOral route1958-04-06activeS

Procedures

ProcedureDatesStatusEvidence
Twelve-lead electrocardiogram: sinus rhythm at 80 per minute, left ventricular hypertrophy by voltage criteria with repolarization changes, no atrial fibrillation, no Q waves1958-03-09 to 1958-03-09completedS
24-hour ambulatory blood pressure monitoring, fitted at the visit and returned the next morning, before the first doses of blood pressure medicine1958-03-09 to 1958-03-09completedS
Transthoracic echocardiography: ejection fraction 62%, concentric left ventricular hypertrophy (septum 13 mm, posterior wall 12 mm), grade II diastolic dysfunction with average E/e' 15, left atrial volume index 38 mL/m2, tricuspid regurgitation velocity 2.8 m/s, no significant valve disease, no pericardial effusion1958-03-23 to 1958-03-23completedS
Twelve-lead electrocardiogram at the sick visit: sinus rhythm at 96 per minute, left ventricular hypertrophy unchanged from intake, no arrhythmia1958-05-18 to 1958-05-18completedS
Advance care planning conversation, about 20 minutes, with her consent1958-09-14 to 1958-09-14completedS

Immunizations

DateVaccineStatusEvidence
1958-03-23Pneumococcal conjugate vaccine PCV20completedS
1958-09-14High-dose influenza vaccine, this seasoncompletedS
1958-09-14Respiratory syncytial virus vaccine, single dosecompletedS
1958-09-14COVID-19 vaccine, mRNA, this seasoncompletedS
1958-10-19Recombinant zoster vaccine, dose 1 of 2completedS
1958-10-19Tetanus, diphtheria, and acellular pertussis vaccine (Tdap)completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

No historical medical events are recorded.

Family History

RelativeConditionAge at deathEvidence
motherDied in 1904, when the patient was 13; cause not recorded in the cited sourceD (CLM-0004)

Health Concerns

ConcernStatusEvidence
She wants to keep teaching, writing and gardening, and to get her breath backactiveS
She cannot afford expensive medicines or extra trips, and food runs short at the end of the monthactiveS
She wants her own account of her symptoms to be believed and every choice explainedactiveS

Assessment

Most recent measures: Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 480 on 1958-03-09; Sodium [Moles/volume] in Serum or Plasma 139 on 1958-10-19; Potassium [Moles/volume] in Serum or Plasma 4.3 on 1958-10-19; Creatinine [Mass/volume] in Serum or Plasma 0.92 on 1958-10-19; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1953)/1.73 sq M 68 on 1958-10-19; Glucose [Mass/volume] in Serum or Plasma 96 on 1958-10-19; Magnesium [Mass/volume] in Serum or Plasma 2 on 1958-10-19; Hemoglobin [Mass/volume] in Blood 12.4 on 1958-03-09; Thyrotropin [Units/volume] in Serum or Plasma 1.9 on 1958-03-09; Hemoglobin A1c/Hemoglobin.total in Blood 5.6 on 1958-03-09; Cholesterol [Mass/volume] in Serum or Plasma 152 on 1958-06-01; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 76 on 1958-06-01; Cholesterol in HDL [Mass/volume] in Serum or Plasma 53 on 1958-06-01; Triglyceride [Mass/volume] in Serum or Plasma 115 on 1958-06-01; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 19 on 1958-06-01; Albumin/Creatinine [Mass Ratio] in Urine 22 on 1958-03-09; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1958-09-14; Left ventricular Ejection fraction 62 on 1958-03-23; Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area 38 on 1958-03-23; Heart valve E velocity/Annulus E wave by US 15 on 1958-03-23; Overall summary score [KCCQ-12] 78 on 1958-10-19; Total score [Mini-Cog] 5 on 1958-09-14; Total score [AUDIT-C] 1 on 1958-09-14 [S]

Strengths and supports: Strengths and supports: raised in Eatonville, an all-Black town she calls home; a lifelong collector of stories; describes a wide circle of friends, students and neighbors, and a sense of humor she relies on [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Very high blood pressure at intake (178/104 and 174/102 mmHg) with morning headaches for two months, without signs of a hypertensive emergency; not previously diagnosed; ambulatory monitoring to confirmresolvedconfirmed R03.0S — Synthetic presenting problem, resolved when ambulatory monitoring and the echocardiogram established the diagnosis at the second visit. Not a claim about her real blood pressure.
Breathlessness on exertion for three months (walking to the school, carrying groceries) with mild ankle swelling by evening; cause to be determinedresolvedconfirmed R06.09S — Synthetic presenting problem, resolved into the heart failure diagnosis at the second visit.
Hypertensive heart disease with heart failure: stage 2 hypertension confirmed by 24-hour ambulatory monitoring (mean 158/96 mmHg, non-dipping at night), with concentric left ventricular hypertrophy on ECG and echocardiogram; synthetic modern episode linked to the hypertensive heart disease recorded as her cause of deathactiveconfirmed I11.0S — Synthetic modern diagnosis made at the second visit; the 1960 cause of death remains D.
Heart failure with preserved ejection fraction (ejection fraction 62%), NYHA class II, with grade II diastolic dysfunction and an enlarged left atriumactiveconfirmed I50.32S — Synthetic modern diagnosis confirmed by echocardiogram and cardiology at the second visit.
Food insecurity: food runs short at the end of most months (Hunger Vital Sign positive)activeconfirmed Z59.41S — Synthetic social need anchored to her documented poverty.
Low and irregular income from substitute teaching and newspaper writing, with Original Medicare but no drug coverage; medicine costs a barrieractiveconfirmed Z59.6S — Synthetic social need anchored to her documented low income in the 1950s.
Orthostatic hypotension with lightheadedness on standing, from volume depletion in early summer heat on a diuretic, spironolactone and an SGLT2 inhibitor; no fall or faint; resolved after two days off those medicines and more fluidresolvedconfirmed I95.1S — Synthetic intercurrent problem at an unscheduled visit; it follows from the treatment plan and the climate and does not echo a documented illness.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1958-03-09Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma480pg/mLBelow 125 pg/mL makes heart failure unlikely outside the hospitalHighS
1958-03-09Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
1958-03-09Potassium [Moles/volume] in Serum or Plasma3.9mmol/L3.5-5.1 mmol/LNormalS
1958-03-09Creatinine [Mass/volume] in Serum or Plasma0.88mg/dL0.59-1.04 mg/dLNormalS
1958-03-09Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1953)/1.73 sq M72mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1958-03-09Glucose [Mass/volume] in Serum or Plasma96mg/dL70-99 mg/dLNormalS
1958-03-09Magnesium [Mass/volume] in Serum or Plasma2mg/dL1.6-2.6 mg/dLNormalS
1958-03-09Hemoglobin [Mass/volume] in Blood12.4g/dL11.6-15 g/dLNormalS
1958-03-09Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.45-4.5 mIU/LNormalS
1958-03-09Hemoglobin A1c/Hemoglobin.total in Blood5.6%<=5.6%NormalS
1958-03-09Cholesterol [Mass/volume] in Serum or Plasma212mg/dL<=199 mg/dLHighS
1958-03-09Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation132mg/dL<=99 mg/dLHighS
1958-03-09Cholesterol in HDL [Mass/volume] in Serum or Plasma54mg/dL>=50 mg/dLNormalS
1958-03-09Triglyceride [Mass/volume] in Serum or Plasma130mg/dL<=149 mg/dLNormalS
1958-03-09Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma18U/L7-35 U/LNormalS
1958-03-09Albumin/Creatinine [Mass Ratio] in Urine22mg/gBelow 30 mg/g is normalNormalS
1958-03-09Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
1958-03-23Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
1958-03-23Potassium [Moles/volume] in Serum or Plasma3.6mmol/L3.5-5.1 mmol/LNormalS
1958-03-23Creatinine [Mass/volume] in Serum or Plasma0.94mg/dL0.59-1.04 mg/dLNormalS
1958-03-23Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1953)/1.73 sq M67mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1958-03-23Glucose [Mass/volume] in Serum or Plasma98mg/dL70-99 mg/dLNormalS
1958-03-23Magnesium [Mass/volume] in Serum or Plasma1.9mg/dL1.6-2.6 mg/dLNormalS
1958-03-23Left ventricular Ejection fraction62%50-70%NormalS
1958-03-23Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area38mL/m2<=34 mL/m²HighS
1958-03-23Heart valve E velocity/Annulus E wave by US15{ratio}<=14HighS
1958-03-23Overall summary score [KCCQ-12]54{score}S
1958-04-06Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
1958-04-06Potassium [Moles/volume] in Serum or Plasma3.4mmol/L3.5-5.1 mmol/LLowS
1958-04-06Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.59-1.04 mg/dLNormalS
1958-04-06Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1953)/1.73 sq M63mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1958-04-06Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
1958-04-06Magnesium [Mass/volume] in Serum or Plasma1.8mg/dL1.6-2.6 mg/dLNormalS
1958-06-01Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
1958-06-01Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
1958-06-01Creatinine [Mass/volume] in Serum or Plasma0.96mg/dL0.59-1.04 mg/dLNormalS
1958-06-01Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1953)/1.73 sq M65mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1958-06-01Glucose [Mass/volume] in Serum or Plasma95mg/dL70-99 mg/dLNormalS
1958-06-01Magnesium [Mass/volume] in Serum or Plasma2mg/dL1.6-2.6 mg/dLNormalS
1958-06-01Cholesterol [Mass/volume] in Serum or Plasma152mg/dL<=199 mg/dLNormalS
1958-06-01Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation76mg/dL<=99 mg/dLNormalS
1958-06-01Cholesterol in HDL [Mass/volume] in Serum or Plasma53mg/dL>=50 mg/dLNormalS
1958-06-01Triglyceride [Mass/volume] in Serum or Plasma115mg/dL<=149 mg/dLNormalS
1958-06-01Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma19U/L7-35 U/LNormalS
1958-06-01Overall summary score [KCCQ-12]72{score}S
1958-05-18Sodium [Moles/volume] in Serum or Plasma136mmol/L135-145 mmol/LNormalS
1958-05-18Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
1958-05-18Creatinine [Mass/volume] in Serum or Plasma1.1mg/dL0.59-1.04 mg/dLHighS
1958-05-18Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1953)/1.73 sq M55mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
1958-05-18Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
1958-09-14Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1958-10-19Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1958-10-19Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
1958-10-19Creatinine [Mass/volume] in Serum or Plasma0.92mg/dL0.59-1.04 mg/dLNormalS
1958-10-19Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1953)/1.73 sq M68mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1958-10-19Glucose [Mass/volume] in Serum or Plasma96mg/dL70-99 mg/dLNormalS
1958-10-19Magnesium [Mass/volume] in Serum or Plasma2mg/dL1.6-2.6 mg/dLNormalS
1958-10-19Overall summary score [KCCQ-12]78{score}S
1958-09-14Total score [Mini-Cog]5{score}S
1958-09-14Total score [AUDIT-C]1{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
1958-03-09Body height165cmS
1958-03-09Body weight84.2kgS
1958-03-09Body mass index (BMI) [Ratio]30.9kg/m2S
1958-03-09Systolic blood pressure176mm[Hg]S
1958-03-09Diastolic blood pressure103mm[Hg]S
1958-03-09Heart rate82/minS
1958-03-09Respiratory rate18/minS
1958-03-09Body temperature36.7CelS
1958-03-09Oxygen saturation in Arterial blood by Pulse oximetry96%S
1958-03-23Body height165cmS
1958-03-23Body weight83.4kgS
1958-03-23Body mass index (BMI) [Ratio]30.6kg/m2S
1958-03-23Systolic blood pressure150mm[Hg]S
1958-03-23Diastolic blood pressure90mm[Hg]S
1958-03-23Heart rate78/minS
1958-03-23Respiratory rate16/minS
1958-03-23Body temperature36.6CelS
1958-03-23Oxygen saturation in Arterial blood by Pulse oximetry97%S
1958-04-06Body height165cmS
1958-04-06Body weight82.6kgS
1958-04-06Body mass index (BMI) [Ratio]30.3kg/m2S
1958-04-06Systolic blood pressure134mm[Hg]S
1958-04-06Diastolic blood pressure82mm[Hg]S
1958-04-06Heart rate76/minS
1958-04-06Respiratory rate16/minS
1958-04-06Body temperature36.7CelS
1958-04-06Oxygen saturation in Arterial blood by Pulse oximetry97%S
1958-06-01Body height165cmS
1958-06-01Body weight81.8kgS
1958-06-01Body mass index (BMI) [Ratio]30kg/m2S
1958-06-01Systolic blood pressure126mm[Hg]S
1958-06-01Diastolic blood pressure76mm[Hg]S
1958-06-01Heart rate72/minS
1958-06-01Respiratory rate16/minS
1958-06-01Body temperature36.6CelS
1958-06-01Oxygen saturation in Arterial blood by Pulse oximetry98%S
1958-10-19Body height165cmS
1958-10-19Body weight81.2kgS
1958-10-19Body mass index (BMI) [Ratio]29.8kg/m2S
1958-10-19Systolic blood pressure124mm[Hg]S
1958-10-19Diastolic blood pressure74mm[Hg]S
1958-10-19Heart rate70/minS
1958-10-19Respiratory rate16/minS
1958-10-19Body temperature36.5CelS
1958-10-19Oxygen saturation in Arterial blood by Pulse oximetry98%S
1958-05-18Body height165cmS
1958-05-18Body weight80.6kgS
1958-05-18Body mass index (BMI) [Ratio]29.6kg/m2S
1958-05-18Systolic blood pressure112mm[Hg]S
1958-05-18Diastolic blood pressure68mm[Hg]S
1958-05-18Heart rate94/minS
1958-05-18Respiratory rate16/minS
1958-05-18Body temperature36.9CelS
1958-05-18Oxygen saturation in Arterial blood by Pulse oximetry97%S
1958-09-14Body height165cmS
1958-09-14Body weight81.6kgS
1958-09-14Body mass index (BMI) [Ratio]30kg/m2S
1958-09-14Systolic blood pressure124mm[Hg]S
1958-09-14Diastolic blood pressure74mm[Hg]S
1958-09-14Heart rate70/minS
1958-09-14Respiratory rate16/minS
1958-09-14Body temperature36.6CelS
1958-09-14Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
1958-03-09Establishing care for morning headaches, breathlessness on exertion and ankle swelling, with very high blood pressure: examination, ECG, laboratory tests, 24-hour ambulatory blood pressure monitoring, a two-drug combination, food and medicine-cost screening, and stroke warning signsfinishedS
1958-03-23Two-week review: ambulatory blood pressure result, echocardiogram, metabolic panel, cardiology consultation the same day, and the diagnosisfinishedS
1958-04-06Two-week review after dapagliflozin: metabolic panel, blood pressure and potassium, and benefits applicationsfinishedS
1958-06-01Eight-week review: blood pressure at home and in the clinic, potassium and kidney function, lipids, KCCQ-12 and drug coveragefinishedS
1958-10-19Seven-month review: blood pressure, heart failure status, metabolic panel, stroke prevention and plans for the yearfinishedS
1958-05-18Same-day sick visit for lightheadedness on standing in the heatfinishedS
1958-09-14Subsequent annual wellness visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Respectful, shared decision-making: take her history as given, explain each test and medicine with its reasons and alternatives, write the plan down, and check costs with her before prescribingcompletedGL-AHA-HTN-2025S
Cardiology consultation on the day of the two-week visit, with the echocardiogram, to confirm the cause of breathlessness, look for hypertensive heart disease and HFpEF and their mimics, and advise on treatmentcompletedGL-HF-2022, GL-HFPEF-2023, GL-CMID-2026S
Confirm the diagnosis with 24-hour ambulatory blood pressure monitoring today, before the first dose; then home readings twice daily with a validated upper-arm monitor and a large cuff lent by the cliniccompletedGL-AHA-HTN-2025, GL-CMID-2026S
Start a two-drug combination for stage 2 hypertension: chlorthalidone 12.5 mg and amlodipine 5 mg every morning, from the morning after the ambulatory monitor is removed, as low-cost generics; target below 130/80 mmHg; less salt, using foods she already eatscompletedGL-AHA-HTN-2025, GL-CMID-2026S
Baseline tests: ECG, NT-proBNP, metabolic panel and magnesium, hemoglobin, TSH, hemoglobin A1c, lipids, ALT and urine albumin-to-creatinine ratio; echocardiogram because of raised NT-proBNP, breathlessness and suspected left ventricular hypertrophycompletedGL-AHA-HTN-2025, GL-HF-2022, GL-CMID-2026S
Stroke and emergency warning signs: BE FAST (balance, eyes, face, arm, speech, time to call 911), and call 911 for chest pain, severe headache with confusion or vision loss, or breathlessness at restcompletedGL-CDC-BEFAST, GL-AHA-HTN-2025S
Costs and coverage, with the clinic's community health worker: a SHINE counselor for Extra Help and the Medicare Savings Program; generic medicines in 90-day fills; patient assistance for any brand-only medicine until coverage beginscompletedGL-EXTRAHELP, GL-MSP, GL-SHINES
Food: the Hunger Vital Sign at intake; help applying for SNAP through ACCESS Florida; the food pantry listcompletedGL-HVS, GL-SNAP, GL-FL-ACCESSS
Heart failure treatment: dapagliflozin 10 mg daily with sick-day rules; daily weights with a written plan; metabolic panel one to two weeks after each start or dose change, then every three to six months; KCCQ-12 every three to six monthscompletedGL-HF-2022, GL-HFPEF-2023, GL-CMID-2026S
Atorvastatin 20 mg daily for primary prevention, with a lipid panel at four to twelve weekscompletedGL-AHA-HTN-2025, GL-CMID-2026S
Add spironolactone 12.5 mg daily for blood pressure above target and low potassium on chlorthalidone; potassium and creatinine one to two weeks latercompletedGL-HF-2022, GL-AHA-HTN-2025S
Laboratory checks on the day of clinic visits where possible, and rides through the county's transportation program for people without a car when a separate trip is neededcompletedGL-CMID-2026S
Heat plan for the Florida summer: fans and cooling places, water through the day, sick-day rules for chlorthalidone, spironolactone and dapagliflozin, and the energy assistance program's cooling helpcompletedGL-HF-2022, GL-LIHEAPS

Goals

GoalTargetStatusOutcomeProvenance
Blood pressure below 130/80 mmHg in the clinic and at home within six months1958-06-01completed126/76 in the clinic; home average 124/74S
Breathlessness only on heavy exertion and a KCCQ-12 score at least 15 points higher within six months1958-10-19completedKCCQ-12 54 to 78; NYHA class I to II; ankles no longer swellS
Every medicine affordable: generic 90-day fills, patient assistance until drug coverage begins, Extra Help and the Medicare Savings Program1958-06-01completedExtra Help and the Medicare Savings Program approved; enrolled in a drug plan; dapagliflozin by patient assistance until thenS
Enough food through the month1958-06-01completedSNAP approved and the food pantry at her church; food lasts the monthS
Know the BE FAST signs of stroke and call 911 at once if any appear1958-04-06completedShe teaches back the signs and keeps the card by the telephoneS

Functional Status

Mental Status